Pedro Beltran
President and CEO, Director · BridgeBio Oncology Therapeutics, Inc.
Individual
- 2025
- Oct 5, 2026
- 6
Other insiders active in the same sector
No other insider has filed at Pedro Beltran's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pedro Beltran?
Pedro Beltran is a corporate insider, tracked as President and CEO, Director of BridgeBio Oncology Therapeutics, Inc. (BBOT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pedro Beltran submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
